Search Results - "Johansson, Bert E."

Changing perspective on immunization against influenza by Johansson, Bert E, Brett, Ian C

“…Abstract Current vaccination strategies against influenza rely on decades old technology of strain selection and prolonged labor-intensive, embryonated…”
Get full text

Immunization against influenza A virus: Comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system by Brett, Ian C., Johansson, Bert E.

“…To simulate the 2003–2004 influenza season and compare available vaccination methods, immunologically naive mice were immunized with: influenza A virus…”
Get full text

Emergency Medical Service Personnel Recognize Pediatric Concussions by Speirs, Joshua N., Lyons, Matthew I., Johansson, Bert E.

“…Concussions are a major cause of morbidity in pediatrics. Many concussions occur during activities with emergency medical service (EMS) providers present to…”
Get full text

Variation in the Divalent Cation Requirements of Influenza A Virus N1 Neuraminidases by Brett, Ian C, Johansson, Bert E

“…Enzymatic kinetic parameters of influenza A virus N1 neuraminidases (NA) chromatographically purified from several vaccine candidate strains were tested. With…”
Get full text

Recombinant Influenza B virus HA and NA antigens administered in equivalent amounts are immunogenically equivalent and induce equivalent homotypic and broader heterovariant protection in mice than conventional and live influenza vaccines by Johansson, Bert E., Brett, Ian C.

“…Influenza B virus is an important cause of acute upper respiratory disease in humans. Vaccination is the primary method of control of influenza related…”
Get full text

A call to cellular & humoral arms: Enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A by McMurry, Julie A., Johansson, Bert E., De Groot, Anne S.

“…Influenza A is an important cause of morbidity and mortality worldwide. In the United States alone influenza kills 30,000 to 50,000 people in a non-epidemic…”
Get full text

Variation in the Divalent Cation Requirements of Influenza A Virus N2 Neuraminidases by Johansson, Bert E., Brett, Ian C.

“…Influenza virus N2 neuraminidases were chromatographically purified from several vaccine candidate strains from 1957 to 1994. Enzymatic kinetic parameters and…”
Get full text

Influenza viral neuraminidase: the forgotten antigen by Johansson, Bert E, Cox, Manon M J

“…Influenza is the most common cause of vaccine-preventable morbidity and mortality despite the availability of the conventional trivalent inactivated vaccine…”
Get more information

Case 3: Acute Onset of Headache, Fever, and Right Arm Weakness in 12-year-old Boy by Chamarthi, Venkata Sushma, Chamarthi, Sastry, Johansson, Bert E

Get full text

Case 3: Acute Onset of Headache, Fever, and Right Arm Weakness in 12-year-old Boy by Chamarthi, Venkata Sushma, Chamarthi, Sastry, Johansson, Bert E

Get full text

Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine by Johansson, Bert E

“…Influenza A virus hemagglutinin (HA) and neuraminidase (NA) from A/Nanchang/933/95 were expressed by recombinant baculovirus-infected insect cell lines. HA and…”
Get full text

Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition by Johansson, Bert E, Pokorny, Barbara A, Tiso, Vincent A

“…Influenza viruses neuraminidase (NA) were chromatographically extracted from influenza viruses A/Nanchang/933/95 H3 NCN2 NC [R] and A/Johannesburg/82/96 H1…”
Get full text

An Inactivated Subvirion Influenza A (H5N1) Vaccine by Johansson, Bert E, Brett, Ian C

“…To the Editor: Treanor et al. (March 30 issue) 1 conducted a well-designed study of a poor vaccine produced by methods that are used in the labor-intensive…”
Get full text

An Inactivated Subvirion Influenza A (H5N1) Vaccine/THE EDITORIALIST REPLIES by Johansson, Bert E, Brett, Ian C, Focosi, Daniele, Poland, Gregory A

“…TO THE EDITOR: [Treanor JJ] et al. (March 30 issue)1 conducted a well-designed study of a poor vaccine produced by methods that are used in the labor-intensive…”
Get full text

Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response by Johansson, Bert E., Matthews, James T., Kilbourne, Edwin D.

“…Influenza virus neuraminidase was chromatographically extracted from A/Johannesburg/33/94 (H3N2) and used to supplement conventional monovalent H3 JHN2 JH…”
Get full text

Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults by Powers, D C, Kilbourne, E D, Johansson, B E

“…Little information is available on the potential role of antibody to influenza virus neuraminidase (NA) in vaccine-induced immunity. In the present study,…”
Get full text

Immunization with Dissociated Neuraminidase, Matrix, and Nucleoproteins from Influenza A Virus Eliminates Cognate Help and Antigenic Competition by Johansson, Bert E., Kilbourne, Edwin D.

“…When hemagglutinin (HA) and neuraminidase (NA) are presented together on an intact influenza virus particle, the antigens are competitive, with HA dominant…”
Get full text

Independent and Disparate Evolution in Nature of Influenza A Virus Hemagglutinin and Neuraminidase Glycoproteins by Kilbourne, Edwin D., Johansson, Bert E., Grajower, Bernardo

“…The hemagglutinin (HA) and neuraminidase (NA) external glycoprotein antigens of H1N1 and H3N2 subtypes of epidemiologically important influenza A viruses…”
Get full text

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans by Kilbourne, Edwin D., Couch, Robert B., Kasel, Julius A., Keitel, Wendy A., Cate, Thomas R., Quarles, John H., Grajower, Bemardo, Pokorny, Barbara A., Johansson, Bert E.

“…The immunogenicity and toxicity of a purified influenza virus (N2) neuraminidase vaccine (NAV) were investigated in 88 human subjects aged 18–40, and compared…”
Get full text

Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice by Johansson, B E, Grajower, B, Kilbourne, E D

“…In studies of infection of young Balb/c mice with a mouse virulent strain of X-31 (H3N2) influenza A virus we have shown a profound virus dose-related effect…”
Get more information